Author

Hsuan-Chung Chen

National Central University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Shu‐Chen LiuiD· 2 shared Tzu-Tung LiuiD· 2 shared Yun-Hua SuiiD· 2 shared Chen-Han HuangiD· 1 shared Chun‐Mei HuiD· 1 shared Chun‐Nan OuYang· 1 shared Fang-Yu TsaiiD· 1 shared Kai-Ping Chang· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Shu‐Chen LiuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Epstein-Barr viral product-containing exosome facilitates LIF-associated immunosuppressive polarization of macrophage in nasopharyngeal carcinoma

Tzu-Tung Liu, Kai‐Ping Chang, Meng-Hsin Li, Yun-Hua Sui, Fang-Yu Tsai, Hsuan-Chung Chen, Chen-Han Huang, Ya‐Wen Chen, Shih Shen Jiang, Shu‐Chen Liu

This study identifies exosome-delivered LMP1 from EBV in NPC as a driver of immunosuppressive macrophage polarization via LIF, promoting tumor progression and immune evasion.

Cancer Letters · Oct 14, 2026Peer-reviewedCancer Biology

Targeting STING-ATM axis overcomes radiotherapy-induced immune suppression and restores anti-tumor immunity in nasopharyngeal carcinoma

Tzu-Tung Liu, Kai-Ping Chang, Yunong Wang, Chun‐Nan OuYang, Ming‐Qing Li, Ngan‐Ming Tsang, Shih Sheng Jiang, Yun-Hua Sui, Chun‐Mei Hu, Yung‐Chih Chou, Hsuan-Chung Chen, Shu‐Chen Liu

This study shows that targeting the STING-ATM axis with a STING agonist overcomes radiotherapy-induced immune suppression in nasopharyngeal carcinoma, enhancing anti-tumor immunity and tumor control.

bioRxiv · Nov 12, 2025 · PreprintCancer Biology